Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: Insights from the HALT study

被引:25
作者
Aerts, Liesbeth [1 ]
Cations, Monica [1 ]
Harrison, Fleur [1 ,2 ]
Jessop, Tiffany [1 ]
Shell, Allan [1 ]
Chenoweth, Lynn [1 ]
Brodaty, Henry [1 ,2 ]
机构
[1] UNSW Sydney, Dementia Ctr Res Collaborat, Sch Psychiat, Sydney, NSW, Australia
[2] UNSW Sydney, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia
关键词
antipsychotic; dementia; deprescribing; nursing; represcribing; PLACEBO-CONTROLLED TRIAL; PERSON-CENTERED CARE; PSYCHOLOGICAL SYMPTOMS; NURSING-HOMES; PSYCHOTROPIC MEDICATIONS; ALZHEIMERS-DISEASE; RESIDENTS; FACILITIES; BEHAVIOR; OUTCOMES;
D O I
10.1002/gps.5167
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Introduction Antipsychotic medications are commonly used to manage behavioural and psychological symptoms of dementia despite their side effects and harms. While the Halting Antipsychotic Use in Long-Term care (HALT) deprescribing trial was successful at reducing antipsychotic use, 19% of participants had their antipsychotics represcribed or never reached a dose of zero. The aim of this study was to investigate the reasons for represcription of antipsychotic medication and factors associated with ongoing antipsychotic use, relating to care staff requests and perceived behavioural changes. Materials and methods Thirty-nine of 133 HALT participants never ceased their antipsychotic medication or were represcribed a regular or pro re nata (PRN) antipsychotic after initial deprescribing. The views of nursing staff, general practitioner, and family on the circumstances leading up to these outcomes were collected via a questionnaire-based approach. This information was triangulated with observation and detailed file audit (including progress notes, medical notes, medication charts, incident reports, and hospital discharge summaries). A consensus panel reconstructed the represcribing context. Results Nurses were the most common drivers of represcribing (63.2%), followed by family members (39.5%), GPs (23.7%), specialists (13.2%), and hospital staff (10.5%). There were multiple drivers for antipsychotic use in 46.2% of participants. Increased agitated and aggressive behaviours were the most commonly reported reasons for represcribing even though these changes were not identified over time on objective measures. Consent and dosage practices remained poor despite education. Discussion Nursing staff are the key drivers of deprescribing particularly in response to perceived worsening agitation and aggression among male residents. The train-the-trainer model used in the HALT trial may have been insufficient on its own to improve staff competence and confidence in applying nonpharmacological approaches when responding to behaviour change.
引用
收藏
页码:1572 / 1581
页数:10
相关论文
共 42 条
[1]   A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial) [J].
Ballard, Clive ;
Lana, Marisa Margallo ;
Theodoulou, Megan ;
Douglas, Simon ;
McShane, Rupert ;
Jacoby, Robin ;
Kossakowski, Katja ;
Yu, Ly-Mee ;
Juszczak, Edmund .
PLOS MEDICINE, 2008, 5 (04) :587-599
[2]   The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial [J].
Ballard, Clive ;
Hanney, Maria Luisa ;
Theodoulou, Megan ;
Douglas, Simon ;
McShane, Rupert ;
Kossakowski, Katja ;
Gill, Randeep ;
Juszczak, Edmund ;
Yu, Ly-Mee ;
Jacoby, Robin .
LANCET NEUROLOGY, 2009, 8 (02) :151-157
[3]  
Banerjee S., 2009, USE ANTIPSYCHOTIC ME
[4]   A Comprehensive Review of the Quality and Feasibility of Dementia Assessment Measures: The Dementia Outcomes Measurement Suite [J].
Bentvelzen, Adam ;
Aerts, Liesbeth ;
Seeher, Katrin ;
Wesson, Jacqueline ;
Brodaty, Henry .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2017, 18 (10) :826-837
[5]   Antipsychotic Use Among Nursing Home Residents [J].
Briesacher, Becky A. ;
Tjia, Jennifer ;
Peterson, Daniel ;
Gurwitz, Jerry H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05) :440-442
[6]   Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study [J].
Brodaty, Henry ;
Aerts, Liesbeth ;
Harrison, Fleur ;
Jessop, Tiffany ;
Cations, Monica ;
Chenoweth, Lynn ;
Shell, Allan ;
Popovic, Gordana C. ;
Heffernan, Megan ;
Hilmer, Sarah ;
Sachdev, Perminder S. ;
Draper, Brian .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2018, 19 (07) :592-+
[7]   Unexplained Variation Across US Nursing Homes in Antipsychotic Prescribing Rates [J].
Chen, Yong ;
Briesacher, Becky A. ;
Field, Terry S. ;
Tjia, Jennifer ;
Lau, Denys T. ;
Gurwitz, Jerry H. .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (01) :89-95
[8]   Critical Contextual Elements in Facilitating and Achieving Success with a Person-Centred Care Intervention to Support Antipsychotic Deprescribing for Older People in Long-Term Care [J].
Chenoweth, Lynn ;
Jessop, Tiffany ;
Harrison, Fleur ;
Cations, Monica ;
Cook, Janet ;
Brodaty, Henry .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[9]  
Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6
[10]   A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents [J].
Chiu, Yunwen ;
Bero, Lisa ;
Hessol, Nancy A. ;
Lexchine, Joel ;
Harrington, Charlene .
HEALTH POLICY, 2015, 119 (06) :802-813